Growth fund research profile
Prosus Ventures is the venture and technology-investing arm of Prosus, backed by an evergreen corporate balance sheet rather than a conventional India-only fund. In India it has built a broad consumer internet, payments, food delivery and marketplace ecosystem.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Prosus Ventures (India) uses a growth / late approach across Payments, food, edtech, commerce.
Current evidence
Prosus reported that it deployed $675M through 2025 into Indian companies including Urban Company, PayU, Rapido, ixigo, Wiom, Deccan AI, CodeKarma and Arivihan; its FY2025 materials also recorded Swiggy's 2024 IPO and stake reduction.
Strategy
Growth / late
Sector focus
Payments, food, edtech, commerce
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Prosus reported that it deployed $675M through 2025 into Indian companies including Urban Company, PayU, Rapido, ixigo, Wiom, Deccan AI, CodeKarma and Arivihan; its FY2025 materials also recorded Swiggy's 2024 IPO and stake reduction.
Investor questions
Prosus Ventures (India) is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Growth / late, with a sector focus of Payments, food, edtech, commerce. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Prosus Ventures (India) in the reviewed public sources: PayU, Swiggy, Meesho, BYJU'S, Urban Company, Rapido, ElasticRun, PharmEasy, DeHaat, Mensa Brands, BlueStone. It does not represent a complete current portfolio unless the manager has published one.
Prosus reported company-level India outcomes in FY2025: a 24.8% fully diluted interest in Swiggy at the reporting date after the IPO, alongside disclosed IRRs reported for Swiggy, PayU India, ElasticRun, Meesho and PharmEasy. These are asset-level figures, not a fund-level India IRR. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: Prosus reported more than $8B invested across 30+ Indian companies over the past decade; the platform invests from an evergreen corporate balance sheet.. Public terms or access information: Growth and late-stage technology investing with strategic operating support across the Prosus ecosystem; no third-party Indian LP terms are offered.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Ervin Tu (interim leadership history). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Post-BYJU'S India strategy; PayU India IPO timeline.
2026-03-25: Prosus reported that it deployed $675M through 2025 into Indian companies including Urban Company, PayU, Rapido, ixigo, Wiom, Deccan AI, CodeKarma and Arivihan; its FY2025 materials also recorded Swiggy's 2024 IPO and stake reduction.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.